The aim of this study was to define the prevalence and spectrum of BRCA1 and BRCA2 mutations in unselected ovarian cancer patients from the Region of Podkarpacie with the use of NGS, and establish an optimal algorithm for genetic testing of women diagnosed with ovarian cancer from this region. This evidence concerns the gene BRCA1 and ovarian cancer.